Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation

Journal of Veterinary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2003, Pages 277-282

  Rickards, K J ^a   Andrews, M J ^a   Waterworth, T H ^a   Alexander, G B C ^a   Cunningham, F M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; APAFANT; CALCIMYCIN; CALCIUM IONOPHORE; CYCLIC AMP; FORSKOLIN; ISOENZYME; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; QUAZINONE; ROLIPRAM; THEOPHYLLINE; THROMBOCYTE ACTIVATING FACTOR; TREQUINSIN; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HORSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENOSINE DIPHOSPHATE; ANIMALS; CYCLIC AMP; HORSES; ISOENZYMES; PHOSPHODIESTERASE INHIBITORS; PLATELET AGGREGATION; THEOPHYLLINE;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0042160244     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2003.00486.x     Document Type: Article

References (31)

1. Bailey, S.R., Elliott, J. & Cunningham, F.M. (2000a) Actions and interactions of ADP. 5-HT, histamine and PAF on equine platelets. Research in Veterinary Science, 68, 175-180.
2. Bailey, S.R., Andrews, M.J., Elliott, J. & Cunningham, F.M. (2000b) Differential activation of platelets from normal and allergic ponies by PAF and ADP. Inflammation Research, 49, 224-231.
3. Billah, M.M. & Lapetina, E.G. (1983) Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. Proceedings of the National Academy of Sciences, USA, 80, 965-968.
4. Burns, G.B. & Dodge, J.A. (1984) Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP. Agents and Actions. 14, 102-108.
5. Cone, J., Wang, S., Tandon, N., Fong, M., Sun, B, Sakurai, K., Yoshitake, M., Kambayashi, J. & Liu, Y. (1999) Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. JournaI of CardiovascuIar Pharmacology, 34, 497-504.
6. Daniel, J.L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J.B. & Kunapuli, S.P. (1998) Molecular basis for ADP-induced platelet aggregation. Journal of Biological Chemistry, 273, 2024-2029.
7. Farndale, R.W., Napthine, C.S., Evans, R.J., Hayes, L.J. & Heath, M.F. (1996) The inhibition of adenylate cyclase in equine platelets by collagen and by platelet-activating factor. Platelets, 7, 43-46.
8. Fawcett, L., Baxendale, R., Stacey, P., McGrouther, C., Harrow, I., Soderling, S. Hetman, J., Beavo, J.A. & Phillips, S.C. (2000) Molecular cloning and characterisation of a distinct human phosphodiesterase gene family: PDE11A. Proceedings of the National Academy of Sciences, USA, 97, 3702-3707.
9. Foster, A.P., Lees, P., Andrews, M.J. & Cunningham, F.M. (1992) Effects of WEB 2086, an antagonist to the receptor for platelet activating factor (PAF), on PAF-induced responses in the horse. Equine Veterinary Journal, 24, 203-207.
10. Halenda, S.P., Jones, W.H. & Shukla, S.D. (1996) Phospholipase D in platelets and megakaryocytic cells. Chemistry and Physics of Lipids, 80, 21-26.
11. Heath, M.F., Evans, R.J., Poole, A.W., Hayes, L.J., McEvoy, R.J. & Littler, R.M. (1994) The effects of aspirin and paracetamol on the aggregation of equine blood platelets. Journal of Veterinary Pharmacology and Therapeutics, 17, 374-378.
12. Holbrook, M. & Coker, S.J. (1991) Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetised rabbits. British Journal of Pharmacology, 103, 1973-1979.
13. Ito, M., Nishikawa, M., Fujioka, M., Miyahara, M., Isaka, N., Shiku, H. & Nakano, T. (1996) Characterisation of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021. Cellular Signalling, 8, 575-581.
14. Jarvis, G.E., Evans, R.J. & Heath, M.F. (1996) The role of ADP in endotoxin-induced equine platelet activation. European Journal of Pharmacology, 315, 203-212.
15. Lanza, F., Beretz, A., Stierle, A., Corre, G. & Cazenave, J.P. (1987) Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilisation. Thrombosis Research, 45, 477-484.
16. Lapetina, E.G. (1982) Platelet-activating factor stimulates the phosphatidylinositol cycle. Journal of Biological Chemistry, 257, 7314-7319.
17. 12 receptor antagonist on the response of equine platelets to ADP. Comparison with human platelets. Research in Veterinary Science, 73, 171-175.
18. 12 receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets. Platelets, 13, 285-292.
19. Meyers, K.M., Lindner, C., Katz, J. & Grant, B. (1979) Characterisation of the equine platelet aggregation response. American Journal of Veterinary Research, 40, 260-264.
20. Misso, N.L. & Thompson, P.J. (1992) Xanthines inhibit human platelet aggregation induced by platelet activating factor. Clinical and Experimental Pharmacology and Physiology, 19, 599-602.
21. Nicholson, C.D. & Shahid, M. (1994) Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes - their potential utility in the therapy of asthma. Pulmonary Pharmacology, 7, 1-17.
22. Poole, A.W., Heath, M.F., Sage, S.O. & Evans, R.J. (1993) A method for loading equine platelets with the fluorescent calcium indicator Fura-2: ADP induces a rise in the cytosolic free calcium ion concentration. Equine Veterinary Journal 25, 45-48.
23. Rink, T.J. & Sage, S.O. (1990) Calcium signalling in human platelets. Annual Review of Physiology, 52, 429-447.
24. Ruppert, D. & Weithmann, K.U. (1982) HL725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro. Life Sciences, 31, 2037-2043.
25. Saenz de Tejada, I., Cuevas, A.J., Fernandez, A., Moncada, I., Allona, A., Lledo, E., Korshen, H.G., Niewohner, U., Haning, H., Pages, E. & Bischoff, E. (2001) The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. International Journal of Impotence Research, 13, 282-290.
26. Scase, T.J. (1998). Blood platelet responses induced by adenosine 5′-diphosphate: functional and molecular studies. PhD thesis, University of Cambridge.
27. Schwarz, U.R., Walter, U. & Eigenthaler, M. (2001) Taming platelets with cyclic nucleotides. Biochemical Pharmacology, 62, 1153-1161.
28. Simpson, A.W., Reeves, M.L. & Rink, T.J. (1988) Effects of SK & F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets. Biochemical Pharmacology, 37, 2315-2320.
29. Sly, M.K., Eberhart, R.C. & Prager, M.D. (1997) Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors. Shock, 8, 115-118.
30. Suquet, C.M. & Leid, R.W. (1983) Aggregation of equine platelets by PAF (platelet activating factor). Inflammation, 7, 197-203.
31. + lymphocytes. Clinical and Experimental Allergy, 25, 616-624.